{"entity":{"type":"insider","cik":"0001672333","url":"/insider/0001672333","json_url":"/insider/0001672333.json","name":"Levy Howard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2018-11-16","last":"2021-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Levy Howard","source":"filing","n_filings":5,"first_seen":"2018-11-16","last_seen":"2021-08-11"}],"transactions":[{"id":4182434,"accession":"0001209191-21-050758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-050758","line_url":"/filing/0001209191-21-050758#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"CATALYST BIOSCIENCES, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001672333","owner_name":"Levy Howard","owner_display_name":"Levy Howard","owner_url":"/insider/0001672333","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":639.0,"shares_display":"639","price_per_share":3.62,"price_display":"3.62","price_state":"stated","total_value":2313.18,"total_display":"2,313.18","total_whole":"2,313","shares_owned_after":639.0,"shares_owned_after_display":"639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider"},{"id":5394393,"accession":"0001209191-21-013036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-013036","line_url":"/filing/0001209191-21-013036#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"CATALYST BIOSCIENCES, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001672333","owner_name":"Levy Howard","owner_display_name":"Levy Howard","owner_url":"/insider/0001672333","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1670.0,"shares_display":"1,670","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":8032.7,"total_display":"8,032.70","total_whole":"8,033","shares_owned_after":23390.0,"shares_owned_after_display":"23,390","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-22","scope":"insider"},{"id":2293180,"accession":"0001209191-20-046347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046347","line_url":"/filing/0001209191-20-046347#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"CATALYST BIOSCIENCES, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001672333","owner_name":"Levy Howard","owner_display_name":"Levy Howard","owner_url":"/insider/0001672333","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1768.0,"shares_display":"1,768","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":8504.08,"total_display":"8,504.08","total_whole":"8,504","shares_owned_after":4268.0,"shares_owned_after_display":"4,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider"},{"id":2109486,"accession":"0001209191-20-019584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-019584","line_url":"/filing/0001209191-20-019584#line-1","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"CATALYST BIOSCIENCES, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001672333","owner_name":"Levy Howard","owner_display_name":"Levy Howard","owner_url":"/insider/0001672333","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.0526,"price_display":"4.05","price_state":"stated","total_value":10131.5,"total_display":"10,131.50","total_whole":"10,132","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-17","scope":"insider"},{"id":6524426,"accession":"0001209191-18-059044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-059044","line_url":"/filing/0001209191-18-059044#line-2","is_derivative":false,"issuer_cik":"0001124105","issuer_name":"CATALYST BIOSCIENCES, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001124105","owner_cik":"0001672333","owner_name":"Levy Howard","owner_display_name":"Levy Howard","owner_url":"/insider/0001672333","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1903.0,"total_display":"1,903.00","total_whole":"1,903","shares_owned_after":7560.0,"shares_owned_after_display":"7,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001124105","name":"CATALYST BIOSCIENCES, INC.","url":"/issuer/0001124105","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2018-11-16","last_seen":"2021-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001672333","retrieved_at":"2026-08-26T19:00:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}